CIMcare Psoriasis Research Study – 6-11 year olds
Are you the parent of a child aged 6-11 who has moderate to severe chronic plaque psoriasis? Your child may be able to participate in a study to explore a potential treatment, known as certolizumab pegol (CZP), to see if it can reduce psoriasis symptoms. Participation will last just over 3 years and involves multiple study visits. Compensation is provided.
